Trends and future directions for HIV research

Despite this, challenges around drug resistance, global disparities in drug access, and lifelong adherence continue to present hurdles.

Gain a comprehensive picture on the current landscape and emerging trends, including:

Evolution of antiretroviral therapy (ART)
Current treatments
Drug market share and forecast
Challenges in developing countries
Future of HIV research

Read the Article

Your company email address

Please select your industry: (max 1)
Yes, I would like to be contacted by an IQVIA expert

Opt In?

Berne Media may store and process my information. For details, see the Privacy Notice.
Citeline (previously Pharma Intelligence UK) may contact me with updates, relevant promotions and information about products. My Information will be used in accordance with the Citeline Privacy Policy, and you withdraw your permission to receive any of our communications at any time.
By clicking submit, you consent to allow IQVIA to store and process the information submitted to provide you the content requested. They are subject to IQVIA Terms and Conditions.

Please complete all required fields to access the content!

Empowering Clinical Research Sites and Sponsors in the Patient-centric Era

What if empowering sites to successfully navigate the challenges of today’s clinical trials was the first step in supporting a patient-centric approach to research? Download your free white paper to explore practical solutions for enabling patient-centric clinical trials by using innovative solutions and technologies for the benefit of sites, sponsors and patients alike. Read now to:

Accelerating Biologics Development With Strategies For Success

The biologics market is growing rapidly, unlocking exciting opportunities but also presenting significant challenges. Developers are undergoing pressure to accelerate the delivery of innovative therapies while addressing complex regulatory demands, navigating demanding clinical trial phases, efficiently scaling production, and maintaining quality. In this webinar, industry experts will share practical strategies and real-world examples to help you navigate these challenges. Key takeaways:

A New Era of Participant Payment Services

Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering: